The US Food and Drug Administration has issued a warning over blood thinner Pradaxa, stating that the drug should not be used in patients mechanical heart valves.
Pradaxa is one of the more popular drugs used in preventing strokes or blood clots in heart patients but a large scale study in Europe, known as RE-ALIGN, was stopped after researchers found that the drug instead increased the risk of strokes and blood clots in patients fitted with mechanical heart valves.
AdvertisementThe FDA recommended that patients who are currently taking Pradaxa, also known as dabigatran, should visit their doctors before switching to a different anticoagulant as they could face other problems if they suddenly stopped taking the drug on their own.
P Sibling Fights Could Indicate Deeper Mental Issues Levitin Horrified on Being Made Role Model for Skinny Girls M
You May Also Like